Biodegradable hollow mesoporous organosilica-based nanosystems with dual stimuli-responsive drug delivery for efficient tumor inhibition by synergistic chemo- and photothermal therapy
Source abstract
Abstract
Abstract Engineering gated porous nanocarriers with multi-stimuli-response is rather fascinating for efficient tumor chemotherapy owing to the avoidance of premature drug leakage and the accurate control of site-specific drug delivery. Herein, a phase-change material (PCM) as a stimuli-responsive ‘‘gate-keeper’’ and copper sulfide (CuS) nanocrystal as a photothermal agent were introduced into biodegradable hollow mesoporous organosilica nanoparticles (HMONs) to construct a multifunctional nanosystem for dual stimuli-responsive drug delivery. The capping of PCM on HMONs enabled the prevention of drug leakage and the temperature-responsive drug release manner, and the reducing-responsive biodegradability of disulfide-hybridized HMONs allowed the tumor microenvironment (TME)-sensitive drug release. With the aid of the near-infrared (NIR)-thermal conversion of CuS nanocrystals, the prepared nanosystem could not only realize both endogenous and external stimuli-triggered drug release, but also achieve synergistic effects of chemo- and photothermal therapy for tumor inhibition. In result, such biocompatible and biodegradable PCM-gated HMONs@CuS nanosystem achieved effective delivery of doxorubicin (DOX) and precise drug release at tumor site, and exhibited remarkable in vitro and in vivo tumor inhibition efficacy by combination of chemotherapy and photothermal therapy, showing great prospect in tumor treatment.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Nanoplatforms for cancer theranostics · Extracellular vesicles in disease · Gas Sensing Nanomaterials and Sensors
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (44)
Show source-provided references
1. Light-Responsive, singlet-oxygen-triggered on-demand drug release from photosensitizer-doped mesoporous silica nanorods for cancer combination therapy10.1002/adfm.201600722 ↗
2. The EPR effect for macromolecular drug delivery to solid tumors: improvement of tumor uptake, lowering of systemic toxicity, and distinct tumor imaging in vivo10.1016/j.addr.2012.10.002 ↗
3. Local drug delivery strategies for cancer treatment: gels, nanoparticles, polymeric films, rods, and wafers10.1016/j.jconrel.2011.11.031 ↗
4. Preparation of magnetic mesoporous silica nanoparticles as a multifunctional platform for potential drug delivery and hyperthermia10.1080/14686996.2016.1178055 ↗
5. Magnetic mesoporous silica nanoparticles coated with thermo-responsive copolymer for potential chemo- and magnetic hyperthermia therapy10.1016/j.micromeso.2017.07.053 ↗
6. Aldehyde-functionalized dendritic mesoporous silica nanoparticles as potential nanocarriers for pH-responsive protein drug delivery10.1016/j.msec.2016.10.039 ↗
7. Metal-organic framework-coated magnetite nanoparticles for synergistic magnetic hyperthermia and chemotherapy with pH- triggered drug release10.1080/14686996.2019.1682467 ↗
8. Focused ultrasound-augmented delivery of biodegradable multifunctional nanoplatforms for imaging-guided brain tumor treatment10.1002/advs.201700474 ↗
9. GSH/pH dual-responsive supramolecular hybrid vesicles for synergistic enzymatic/chemo-tumor therapy
10. Gated mesoporous silica nanocarriers for hypoxia-responsive cargo release10.1021/acsami.9b04142 ↗
11. A pH/ROS cascade-responsive charge-reversal nanosystem with self-amplified drug release for synergistic oxidation-chemotherapy10.1002/advs.201801807 ↗
12. Magnetic resonance imaging-guided multi-drug chemotherapy and photothermal synergistic therapy with pH and NIR-Stimulation release10.1021/acsami.7b06105 ↗
13. Graphene quantum dots-capped magnetic mesoporous silica nanoparticles as a multifunctional platform for controlled drug delivery
14. Complete regression of local cancer using temperature-sensitive liposomes combined with ultrasound-mediated hyperthermia10.1016/j.jconrel.2013.08.019 ↗
15. Hollow mesoporous organosilica nanoparticles: a generic intelligent framework-hybridization approach for biomedicine10.1021/ja508721y ↗
16. Ultrasmall mesoporous organosilica nanoparticles: morphology modulations and redox-responsive biodegradability for tumor-specific drug delivery10.1016/j.biomaterials.2018.01.046 ↗
17. Large-pore ultrasmall mesoporous organosilica nanoparticles: micelle/Precursor co-templating assembly and nuclear-targeted gene delivery10.1002/adma.201404256 ↗
18. Nanocatalytic tumor therapy by biomimetic dual inorganic nanozyme-catalyzed cascade reaction10.1002/advs.201801733 ↗
19. Tumor-selective catalytic nanomedicine by nanocatalyst delivery10.1038/s41467-017-00424-8 ↗
20. Molecularly organic/inorganic hybrid hollow mesoporous organosilica nanocapsules with tumor-specific biodegradability and enhanced chemotherapeutic functionality10.1016/j.biomaterials.2017.02.018 ↗
21. Metalloporphyrin-Encapsulated biodegradable nanosystems for highly efficient magnetic resonance imaging-guided sonodynamic cancer therapy10.1021/jacs.6b11846 ↗
22. Chemistry of mesoporous organosilica in nanotechnology: molecularly organic-inorganic hybridization into frameworks10.1002/adma.201505147 ↗
23. Enzymatically degradable hybrid organic–inorganic bridged silsesquioxane nanoparticles for in vitro imaging10.1039/C5NR03065J ↗
24. A facile multi-interface transformation approach to monodisperse multiple shelled periodic mesoporous organosilica hollow spheres10.1021/jacs.5b05369 ↗
25. Mesoporous silica/organosilica nanoparticles: synthesis, biological effect and biomedical application10.1016/j.mser.2019.01.001 ↗
26. A versatile stimulus-responsive metal–organic framework for size/morphology tunable hollow mesoporous silica and pH-triggered drug delivery10.1039/C6TB03379B ↗
27. DNA-capped Fe3O4/SiO2 magnetic mesoporous silica nanoparticles for potential controlled drug release and hyperthermia10.1039/C5RA00701A ↗
28. Emerging applications of phase-change materials (PCMs): teaching an old dog new tricks10.1002/anie.201305201 ↗
29. A temperature-sensitive drug release system based on phase-change materials10.1002/anie.201004057 ↗
30. A new theranostic system based on gold nanocages and phase-change materials with unique features for photoacoustic imaging and controlled release10.1021/ja200894u ↗
31. Biocompatible and biodegradable zeolitic imidazolate framework/polydopamine nanocarriers for dual stimulus triggered tumor thermo-chemotherapy10.1016/j.biomaterials.2018.02.022 ↗
32. Mesoporous silica nanoparticles capped with graphene quantum dots for potential chemo- and photothermal synergistic cancer therapy10.1021/acs.langmuir.6b04189 ↗
33. Precision cancer theranostic platform by in situ polymerization in perylene diimide-hybridized hollow mesoporous organosilica nanoparticles10.1021/jacs.9b06086 ↗
34. Cascade-amplifying synergistic effects of chemo-photodynamic therapy using ROS-responsive polymeric nanocarriers10.7150/thno.24015 ↗
35. Light-Triggered retention and cascaded therapy of albumin-based theranostic nanomedicines to alleviate tumor adaptive treatment tolerance
36. A hollow-structured cus@cu2s@au nanohybrid: synergistically enhanced photothermal efficiency and photoswitchable targeting effect for cancer theranostics10.1002/adma.201701266 ↗
37. A core/satellite multifunctional nanotheranostic for in vivo imaging and tumor eradication by radiation/photothermal synergistic therapy10.1021/ja404985w ↗
38. Nanocellulose templated growth of ultra-small bismuth nanoparticles for enhanced radiation therapy10.1039/C7NR06462D ↗
39. Metal-Organic framework/graphene quantum dot nanoparticles used for synergistic Chemo- and Photothermal therapy10.1021/acsomega.6b00385 ↗
40. Magnetic iron oxide nanoparticles/10-hydroxy camptothecin co-loaded nanogel for enhanced photothermal-chemo therapy10.1016/j.apmt.2018.11.008 ↗
41. Nanocarriers as an emerging platform for cancer therapy10.1038/nnano.2007.387 ↗
42. NIR-to-NIR deep penetrating nanoplatforms YO3:Nd3+/Yb3+@SiO2@Cu2S toward highly efficient photothermal ablation10.1021/acsami.8b03239 ↗
43. Naderi · 2015 · 585
44. Design and functionalization of the NIR-Responsive photothermal semiconductor nanomaterials for cancer theranostics10.1021/acs.accounts.7b00294 ↗